Title |
The mammalian Hippo pathway: regulation and function of YAP1 and TAZ
|
---|---|
Published in |
Cellular and Molecular Life Sciences, September 2014
|
DOI | 10.1007/s00018-014-1742-9 |
Pubmed ID | |
Authors |
Manami Kodaka, Yutaka Hata |
Abstract |
The Hippo pathway was originally identified as the signaling that controls organ size in Drosophila, with the core architecture conserved in mammals. In the mammalian Hippo pathway, mammalian Ste20-like kinases (MST1/2) and large tumor suppressor kinases (LATS1/2) regulate transcriptional co-activators, Yes-associated protein (YAP1) and Transcriptional co-activator with a PDZ-binding motif (TAZ). The Hippo pathway was initially thought to be quite straightforward; however, the identification of additional components has revealed its inherent complexity. Regulation of YAP1 and TAZ is not always dependent on MST1/2 and LATS1/2. MST1/2 and LATS1/2 play various YAP1/TAZ-independent roles, while YAP1 and TAZ cross-talk with other signaling pathways. In this review we focus on YAP1 and TAZ and discuss their regulation, function, and the consequences of their dysregulation. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 1% |
Japan | 1 | <1% |
Netherlands | 1 | <1% |
Canada | 1 | <1% |
Unknown | 143 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 30 | 20% |
Researcher | 28 | 19% |
Student > Master | 18 | 12% |
Student > Bachelor | 16 | 11% |
Professor > Associate Professor | 8 | 5% |
Other | 25 | 17% |
Unknown | 23 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 43 | 29% |
Biochemistry, Genetics and Molecular Biology | 38 | 26% |
Medicine and Dentistry | 19 | 13% |
Neuroscience | 9 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
Other | 7 | 5% |
Unknown | 29 | 20% |